HBSP (USA)
-
Globalization and the Welfare State (Spanish version)
Daemmrich, Arthur A.; Kramarz, BenjaminCase HBS-715S01EconomicsThis case describes how Denmark has balanced the impacts of globalization, including outsourcing and movement of labor with its social welfare offerings. Reforms implemented during the past two decades drove down unemployment, promoted new company formation, and put the country at or near the top of international polls on the ease of doing business. The case describes how Danes forged a consensus that embraced international trade and outsourcing ...Starting at €8.20
-
Modelos multifactoriales
Baker, Malcolm P.Case HBS-209S04FinanceLos estudiantes evalúan el desempeño de los cuatro fondos de inversión y calcular el costo de capital para las empresas que utilizan dos puntos de referencia fijos, el CAPM, y un modelo multifactorial de los retornos.Starting at €8.20
-
Telecommunications Regulation and Coordinated Competition in Romania
Daemmrich, Arthur A.; Radu, Alex; Sarbu, AnaCase HBS-713016-EEconomicsLeaders of the Romanian telecommunications agency must decide about a proposed international merger and how to structure bandwidth auctions critical to the telecoms market. The case is designed to teach about regulatory choices from the perspective of a regulatory agency, but it also describes the competitive standing of domestic and international telecoms providers in Romania and the challenges of operating as a "foreign" multinational, even in ...Starting at €8.20
-
Telecommunications Regulation and Coordinated Competition in Romania, Teaching Note
Daemmrich, Arthur A.Teaching Note HBS-713017-EEconomicsTeaching Note for 713016Starting at €0.00
-
Denmark: Globalization and the Welfare State, Teaching Note
Daemmrich, Arthur A.Teaching Note HBS-710007-EEconomicsTeaching Note for [709015].Starting at €0.00
-
International Lobbying and The Dow Chemical Company (B): Regulatory Reform in the USA
Daemmrich, Arthur A.Case HBS-710028-EEconomicsStarting at €5.74
-
International Lobbying and the Dow Chemical Company (PPT)
Daemmrich, Arthur A.Case HBS-711089-EEconomicsTo be used with cases 710027 and 710028.Starting at €8.20
-
U.S. Healthcare Reform: Reaction to the Patient Protection and Affordable Care Act of 2010
Daemmrich, Arthur A.Case HBS-711103-EEconomicsSupplement to "U.S. Healthcare Reform: International Perspectives," HBS No. 710-040, updating key events and disputes concerning the reform law, including the 2010 Congressional elections, legislative proposals, legal challenges, and responses by employers.Starting at €8.20
-
Celgene
Baker, Malcolm P.; McComb, Emily R.Case HBS-218094-EFinanceIn February 2011, Adam Koppel, a Managing Director at Brookside Capital, the public equity arm of Bain Capital, must decide whether to increase or exit the firm's position in Celgene Corporation. News has emerged that raises potential safety concerns associated with Celgene's key drug, Revlimid. In response, Celgene's share price has traded down 20% in the last two months, and is now almost 10% below the level where Brookside made their initial i...Starting at €8.20
-
Matrix Capital Management (C)
Baker, Malcolm P.; Lane, DavidCase HBS-211060-EFinanceBen Balbale, a partner at hedge fund Matrix Capital, must decide whether to exit their investment in Rovi Corporation, a company with a diverse portfolio of patents used primarily for digital interactive guides. Rovi's shares are up over 50% from the time Balbale initiated a position in the middle of 2009.Starting at €5.74